Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;17(4):336-41.
doi: 10.1089/gtmb.2012.0391. Epub 2013 Feb 28.

Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity

Suad AlFadhli  1
Affiliations

Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity

Suad AlFadhli. Genet Test Mol Biomarkers. 2013 Apr.

Abstract

Aim: To explore the potential genetic association of CTLA-4 Exon1 +49A/G and 3'UTR (AT)(n) to susceptibility to systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and overlapping (OP) autoimmunity; affected with more than one autoimmune disease. Expression of two major CTLA-4 isoforms; full length (mCTLA-4) and soluble (sCTLA-4) were explored in all subjects. A total of 680-age/gender/ethnically matched Kuwaitis were recruited and polymerase chain reaction (PCR)-fragment analysis was employed for genotyping both markers. mCTLA-4 and sCTLA-4 mRNA expression were analyzed using quantitative real time-PCR. The enzyme-linked immunosorbent assay (ELISA) was used to screen sCTLA-4 in all subjects' sera.

Results: Only two CTLA-4 3'UTR (AT)(n) allelotypes; (AT)(15) and (AT)(6) were detected. The heterozygous (AT)(15/6) genotype confers protectivity rather than susceptibility to SLE (p=0.01, odds ratio=0.43, and confidence interval=0.21-0.86). No significant association was observed between Exon 1 +49A/G and any of the tested diseases. A consistently high serum sCTLA-4 level was observed in RA (6.8 ng/mL, p=0.005), SLE (6.34 ng/mL, p=0.007), and OP (8.75 ng/mL, p=0.012) compared to healthy control. A significant increase in the expression of sCTLA-4 mRNA was observed in OP (p=0.05) and SLE (p=0.047), while a significant increase in the expression of mCTLA-4 (p=0.01) was observed only in OP.

Conclusion: The present study is the first to report a statistically significant association between OP and serum sCTLA-4. The novelty of our study is the significance of CTLA-4 in the pathogenesis of OP besides SLE and RA.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Serum soluble form CTLA-4 (sCTLA-4) found in autoimmune patients, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), overlapping (OP), and healthy control (HC). The concentration of serum sCTLA-4 in a total of 134 autoimmune patients and 68 healthy controls were analyzed using the ELISA test. Results are expressed in ng/mL.
See this image and copyright information in PMC

References

    1. Aguilar F. Torres B. Sanchez-Roman J, et al. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum Immunol. 2003;64:936–940. - PubMed
    1. Ahmed S. Ihara K. Kanemitsu S, et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus Erythematosus in the Japanese population. Rheumatol Oxford. 2001;40:662–667. - PubMed
    1. AlFadhli S. Kharrat N. AlRebai A. Genome scan meta- analysis in systemic lupus erythematosus strong linkage with loci 6p22.3-p21.1 and 2q31.1–34. J Med Genet Genomics. 2010;2:001–009.
    1. Anjos S. Nguyen A. Ounissi-Benkalha H, et al. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4. J BiolChem. 2002;277:46478–46486. - PubMed
    1. Ban Y. Davies TF. Greenberg DA, et al. Analysis of the CTLA-4, CD-28, and inducible co-stimulatory (ICOS) gene in thyroid diseases. Genes Immun. 2003;4:586–593. - PubMed

Publication types

MeSH terms

LinkOut - more resources